Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination

Bridgid E. Hast, Erica W. Cloer, Dennis Goldfarb, Heng Li, Priscila F. Siesser, Feng Yan, Vonn Walter, Ning Zheng, D. Neil Hayes, Michael B. Major

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination'. Together they form a unique fingerprint.

Medicine & Life Sciences